Actively Recruiting
Role of HbA1c in Predicting Adverse Pregnancy Outcomes
Led by National University of Malaysia · Updated on 2024-11-06
195
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to determine the reference value of HbA1c that can be used to predict adverse pregnancy outcomes. These adverse outcomes include LGA fetus, shoulder dystocia, caesarean section, pre-term birth, pre-eclampsia and fetal neonatal hypoglycaemia.
CONDITIONS
Official Title
Role of HbA1c in Predicting Adverse Pregnancy Outcomes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant woman with singleton pregnancy
- Confirmed diagnosis of GDM based on Malaysia CPG (5.1/7.8)
- HbA1c level taken at least once at any time during the pregnancy
- Delivery after 28 weeks gestation
You will not qualify if you...
- Major fetal anomaly
- Haemoglobin level of 9 g/dL (moderate or severe anaemia in pregnancy)
- Women with autoimmune diseases
- Overt diabetes or pre-existing diabetes
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Obstetrics & Gynaecology, Hospital Canselor Tuanku Muhriz
Cheras, Kuala Lumpur, Malaysia, 56000
Actively Recruiting
Research Team
R
Rahana ARahman, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here